Cite
MLA Citation
E. Raffoux et al.. “PB1805: INSIGHTS FROM ORAL AZACITIDINE EARLY ACCESS PROGRAM IN FRANCE: PATIENT POPULATION WITH ACUTE MYELOID LEUKEMIA RECEIVING ORAL-AZA FOR MAINTENANCE OF COMPLETE REMISSION AFTER INDUCTION CHEMOTHERAPY.” HemaSphere, vol. 6, n.d., pp. 1685–1686. http://access.bl.uk/ark:/81055/vdc_100158013693.0x000032